Shi Weikang, He Huiyi, Jiang Jicong, Gao Yu, Quan Hehe
Department of Dermatology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang Province, People's Republic of China.
Clin Cosmet Investig Dermatol. 2021 Nov 2;14:1593-1599. doi: 10.2147/CCID.S337850. eCollection 2021.
Infantile hemangioma (IH) is the most common benign tumor in infancy, and superficial IH is the most common type. IH can reportedly resolve spontaneously, but this is associated with complications, such as scars, atrophy, hypopigmentation, telangiectasia, and skin sagging, in 70% of cases. This study explores the safety and feasibility of therapeutic intervention with the 595-nm pulsed-dye laser (PDL) combined with 0.5% timolol maleate solution in superficial IH and compares the difference in efficacy between the early group and the late group.
This retrospective study examined 167 patients with superficial IH who underwent combination therapy at the Dermatology Clinic of the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University between July 2019 and July 2020. The early and late groups were composed of children aged ≤2 and >2 months, respectively. Treatment was administered for 6 months, and patients were followed up for another 6 months. Two independent, double-blinded physicians reviewed photographs of the skin lesions before and after treatment to evaluate efficacy.
The early group demonstrated higher treatment efficacy than the late group. The early (n = 45) and late (n = 122) groups had treatment efficacy rates of 95.5% and 86.1%, respectively; the difference was statistically significant (< 0.05). The early and late groups underwent 3.51 ± 0.50 and 4.73 ± 0.68 months of treatment, respectively; the difference was statistically significant (< 0.05). Seventeen (44.4%) patients in the early group had immediate adverse reactions but no permanent sequelae, whereas 25 (20.49%) and 13 (10.7%) patients in the late group had immediate and permanent sequelae, respectively. The difference was statistically significant (<0.05).
This retrospective study demonstrated that 595-nm PDL combined with 0.5% timolol maleate solution was a safe and effective local treatment for superficial IH. Early treatment required fewer treatments, had better curative effects, and a lower probability of permanent sequelae.
婴儿血管瘤(IH)是婴儿期最常见的良性肿瘤,浅表型IH最为常见。据报道,IH可自发消退,但70%的病例会伴有诸如瘢痕、萎缩、色素减退、毛细血管扩张和皮肤松弛等并发症。本研究探讨595纳米脉冲染料激光(PDL)联合0.5%马来酸噻吗洛尔溶液治疗浅表型IH的安全性和可行性,并比较早期治疗组和晚期治疗组的疗效差异。
本回顾性研究对2019年7月至2020年7月期间在温州医科大学附属第二医院皮肤科门诊及育英儿童医院接受联合治疗的167例浅表型IH患者进行了研究。早期治疗组和晚期治疗组分别由年龄≤2个月和>2个月的儿童组成。治疗为期6个月,患者随后又接受了6个月的随访。两名独立的、双盲的医生查看治疗前后皮肤病变的照片以评估疗效。
早期治疗组的治疗效果高于晚期治疗组。早期治疗组(n = 45)和晚期治疗组(n = 122)的治疗有效率分别为95.5%和86.1%;差异具有统计学意义(<0.05)。早期治疗组和晚期治疗组分别接受了3.51±0.50个月和4.73±0.68个月的治疗;差异具有统计学意义(<0.05)。早期治疗组有17例(44.4%)患者出现即刻不良反应,但无永久性后遗症,而晚期治疗组分别有25例(20.49%)和13例(10.7%)患者出现即刻和永久性后遗症。差异具有统计学意义(<0.05)。
本回顾性研究表明,595纳米PDL联合0.5%马来酸噻吗洛尔溶液是治疗浅表型IH的一种安全有效的局部治疗方法。早期治疗所需治疗次数更少,疗效更好,出现永久性后遗症的概率更低。